• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>EFSA Journal >Annual assessment of Echinococcus?multilocularis surveillance reports submitted in 2018 in the context of Commission Regulation (EU) No?1152/2011
【24h】

Annual assessment of Echinococcus?multilocularis surveillance reports submitted in 2018 in the context of Commission Regulation (EU) No?1152/2011

机译：根据欧盟法规（EU）第1152/2011号，2018年提交的多球棘球E虫监视报告的年度评估

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

This report is part of the `Echinococcus multilocularis surveillance’ scientific reports which are presented annually by EFSA to the European Commission and are intended to assess the sampling strategy, data collection and detection methods used by Finland, Ireland, Malta, the United Kingdom (UK) and Norway in their respective surveillance programmes. The surveillance programmes of these five countries were evaluated by checking the information submitted by each of them and verifying that the technical requirements laid down in Regulation (EU) No 1152/2011 were complied. The information was divided in four different categories for assessment: the type and sensitivity of the detection method, the selection of the target population, the sampling strategy and the methodology. For each category, the main aspects that need to be considered in order to accomplish the technical requirements of the legislation were checked against compliance of several criteria. All of the countries participating in this surveillance (Finland, the UK, Norway, Malta and Ireland) succeeded in the fulfilment of the technical legal requirements foreseen in Regulation (EU) No 1152/2011 concerning these four different categories. Northern Ireland (UK) fulfils those requirements only when assuming a diagnostic test sensitivity value of 0.99, which is higher than the sensitivity value suggested by EFSA (conservative value of 0.78). None of the five countries recorded positive samples in the 12‐month reporting period.
机译：该报告是欧洲食品安全局（EFSA）每年向欧洲委员会提交的“多球棘球菌监测”科学报告的一部分，旨在评估芬兰，爱尔兰，马耳他，英国（英国）使用的采样策略，数据收集和检测方法）和挪威各自的监视计划。通过检查每个国家/地区提交的信息并验证是否符合法规（EU）1152/2011规定的技术要求，对这五个国家/地区的监视计划进行了评估。信息分为四个不同类别进行评估：检测方法的类型和敏感性，目标人群的选择，抽样策略和方法。对于每个类别，要检查是否达到了立法的技术要求需要考虑的主要方面，并与若干标准的遵守情况进行了检查。参与此监视的所有国家（芬兰，英国，挪威，马耳他和爱尔兰）都成功满足了关于这四个不同类别的第（EU）1152/2011号法规中预期的技术法律要求。北爱尔兰（英国）仅在假设诊断测试灵敏度值为0.99时才满足这些要求，该灵敏度值高于EFSA建议的灵敏度值（保守值0.78）。在12个月的报告期内，五个国家均未记录到阳性样本。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号